Biosplice Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Biosplice Therapeutics's estimated annual revenue is currently $7M per year.
- Biosplice Therapeutics's estimated revenue per employee is $155,000
- Biosplice Therapeutics's total funding is $884M.
- Biosplice Therapeutics's current valuation is $12B.
Employee Data
- Biosplice Therapeutics has 45 Employees.
- Biosplice Therapeutics grew their employee count by -34% last year.
Biosplice Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Medical Officer | Reveal Email/Phone |
3 | VP, Biometrics | Reveal Email/Phone |
4 | VP Corporate Finance | Reveal Email/Phone |
5 | VP Discovery Research | Reveal Email/Phone |
6 | VP, Clinical Development and External Innovation | Reveal Email/Phone |
7 | Executive Director, Portfolio & Programs Management | Reveal Email/Phone |
8 | Associate Director, Statistical Programming | Reveal Email/Phone |
9 | Associate Director, Risk-Based Quality Management (RBQM) | Reveal Email/Phone |
10 | Director, Tumor Biology | Reveal Email/Phone |
Biosplice Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Biosplice Therapeutics?
$884M
Total Funding
45
Number of Employees
$7M
Revenue (est)
-34%
Employee Growth %
$12B
Valuation
N/A
Accelerator
Biosplice Therapeutics News
2022-04-20 - GV, Sanofi drive British biotech OMass to $100M series B ...
... Ventures have joined forces to pump $100 million into OMass Therapeutics, ... Biosplice: Once worth $12 billion, Biosplice laid off 41 workers in early...
2022-04-19 - 2 become 1: Caladrius and Cend merge into tumor-focused ...
That's how Caladrius Biosciences and Cend Therapeutics have described their ... Biosplice: Once worth $12 billion, Biosplice laid off 41 workers in early...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5M | 45 | 61% | N/A |
#2 | $1.7M | 45 | -4% | N/A |
#3 | $7.3M | 45 | -27% | N/A |
#4 | $7M | 45 | 18% | N/A |
#5 | $11.3M | 45 | -8% | $97.3M |